SOURCE: Remedent, Inc.

Remedent, Inc.

August 19, 2014 10:03 ET

Remedent Announces Availability of Its Online Presentation as of Tuesday, August 19, 2014

GHENT, BELGIUM--(Marketwired - Aug 19, 2014) - Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the first quarter ended June 30th 2014.

The online presentation will be available on the Remedent website as of August 19th (www.remedent.com/investors).

About Remedent:
Remedent Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 28 countries worldwide.

For more information, go to www.remedent.com

Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q.

Contact Information

  • For more info, please contact:
    Mr Luc Maes
    Marketing Manager Remedent
    Zuiderlaan 1-3 box 8, 9000 Gent - Belgium
    T: +32 (0)9-2415880
    E: info@remedent.com
    W: www.remedent.com